<!-- received="Tue Aug 17 18:54:21 1999 MDT" -->
<!-- sent="Tue, 17 Aug 1999 19:00:18 +0200" -->
<!-- name="Gabriele Betti" -->
<!-- email="lbetti@dinonet.it" -->
<!-- subject="Re: fibrogen and heart disease" -->
<!-- id="19990817170549111.AAA223@p10032" -->
<!-- inreplyto="000101bee894$570fa700$e62fd8c0@binky" -->
<!-- version=1.10, linesinbody=94 -->
<html><head><title>extropians: Re: fibrogen and heart disease</title>
<meta name=author content="Gabriele Betti">
<link rel=author rev=made href="mailto:lbetti@dinonet.it" title ="Gabriele Betti">
</head><body>
<h1>Re: fibrogen and heart disease</h1>
Gabriele Betti (<i>lbetti@dinonet.it</i>)<br>
<i>Tue, 17 Aug 1999 19:00:18 +0200</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#2325">[ date ]</a><a href="index.html#2325">[ thread ]</a><a href="subject.html#2325">[ subject ]</a><a href="author.html#2325">[ author ]</a>
<!-- next="start" -->
<li><a href="2326.html">[ Next ]</a><a href="2324.html">[ Previous ]</a>
<b>In reply to:</b> <a href="2263.html">Elizabeth Childs</a>
<!-- nextthread="start" -->
<b>Next in thread:</b> <a href="2329.html">Patrick Wilken</a>
</ul>
<!-- body="start" -->

<p>
<a name="2329qlink1">I wonder why I have to pay to get what I need!</a>
Gabriele


<p>
At 01.19 17/08/99 -0700, you wrote:
<br>
<a href="2263.html#2325qlink1">&gt;The Life Extension Foundation provides a Fibrinogen test without requiring a</a><br>
<i>&gt;prescription from a doctor:  It's $55:</i><br>
<i>&gt;<a href="http://www.lef.org/newshop/cgi-shop/showCategory.cgi?catid=23000">http://www.lef.org/newshop/cgi-shop/showCategory.cgi?catid=23000</a></i><br>
<i>&gt;</i><br>
<i>&gt;I vaguely recall that there's a way to reduce Fibrinogen with supplements,</i><br>
<i>&gt;so I believe it's worth taking the test.</i><br>
<i>&gt;</i><br>
<i>&gt;They also do Homocysteine for $110.  High homocysteine is also associated</i><br>
<i>&gt;with heart attack.  It can be reduced with a B vitamin.</i><br>
<i>&gt;</i><br>
<i>&gt;I have no association with the LEF and I don't know anything about their</i><br>
<i>&gt;tests in specific.</i><br>
<i>&gt;</i><br>
<i>&gt;I'm curious if anyone has an opinion on their cancer profile.</i><br>
<i>&gt;</i><br>
<i>&gt;Elizabeth Childs</i><br>
<i>&gt;echilds@linex.com</i><br>
<i>&gt;Yoda's Witness</i><br>
<i>&gt;</i><br>
<i>&gt;----- Original Message -----</i><br>
<i>&gt;From: Doug Skrecky &lt;oberon@vcn.bc.ca&gt;</i><br>
<i>&gt;To: &lt;extropians-digest@extropy.com&gt;</i><br>
<i>&gt;Sent: Monday, August 16, 1999 3:12 PM</i><br>
<i>&gt;Subject: fibrogen and heart disease</i><br>
<i>&gt;</i><br>
<i>&gt;</i><br>
<i>&gt;&gt; Authors</i><br>
<i>&gt;&gt;   Woodward M.  Lowe GD.  Rumley A.  Tunstall-Pedoe H.</i><br>
<i>&gt;&gt; Institution</i><br>
<i>&gt;&gt;   Cardiovascular Epidemiology Unit, University of Dundee, Scotland.</i><br>
<i>&gt;&gt; Title</i><br>
<i>&gt;&gt;   Fibrinogen as a risk factor for coronary heart disease and</i><br>
<i>&gt;&gt;   mortality in middle-aged men and women. The Scottish Heart</i><br>
<i>&gt;&gt;   Health Study.</i><br>
<i>&gt;&gt; Source</i><br>
<i>&gt;&gt;   European Heart Journal.  19(1):55-62, 1998 Jan.</i><br>
<i>&gt;&gt; Abstract</i><br>
<i>&gt;&gt;   AIMS: Fibrinogen was measured in 5095 men and 4860 men aged</i><br>
<i>&gt;&gt;   40-59 in a random population sample from 25 districts of Scotland</i><br>
<i>&gt;recruited</i><br>
<i>&gt;&gt;   during 1984-87: the Scottish Heart Health Study. Fibrinogen</i><br>
<i>&gt;&gt;   was then related to the chance of fatal and non-fatal coronary events</i><br>
<i>&gt;and</i><br>
<i>&gt;&gt;   death from any cause during a subsequent follow-up period of around 8</i><br>
<i>&gt;years.</i><br>
<i>&gt;&gt;   METHODS AND RESULTS: Fibrinogen was measured by the Clauss</i><br>
<i>&gt;&gt;   assay. The effect of fibrinogen on coronary heart disease</i><br>
<i>&gt;&gt;   and death was assessed through age-adjusted means and Cox proportional</i><br>
<i>&gt;&gt;   hazards regression models, accounting for age, cotinine (a measure of</i><br>
<i>&gt;tobacco</i><br>
<i>&gt;&gt;   smoke inhalation) and 11 other major coronary risk factors.</i><br>
<i>&gt;&gt;   Fibrinogen was found to be an important risk factor for</i><br>
<i>&gt;&gt;   coronary heart disease in men and women, with and without pre-existing</i><br>
<i>&gt;&gt;   coronary heart disease. There appears to be a threshold effect, with</i><br>
<i>&gt;those in</i><br>
<i>&gt;&gt;   the highest fifth of the distribution having a much increased risk.</i><br>
<i>&gt;Estimated</i><br>
<i>&gt;&gt;   age-adjusted hazard ratios by sex and pre-existing coronary heart</i><br>
<i>&gt;disease</i><br>
<i>&gt;&gt;   group for the highest to lowest fifth of fibrinogen range</i><br>
<i>&gt;&gt;   between 1.93 and 4.86. Fibrinogen is also important as a</i><br>
<i>&gt;&gt;   risk factor for coronary death and all-causes mortality,</i><br>
<i>&gt;&gt;   with a similar threshold effect. Comparing the two extreme fifths, the</i><br>
<i>&gt;hazard</i><br>
<i>&gt;&gt;   ratios for coronary death are 3.01 and 3.42, and for all-cause</i><br>
<i>&gt;&gt;   mortality are 2.59 and 2.20, for men and women respectively.</i><br>
<i>&gt;&gt;   Adjustment for cotinine reduces the hazard ratios, but further</i><br>
<i>&gt;adjustment for</i><br>
<i>&gt;&gt;   the other 11 risk factors has little effect for coronary heart disease</i><br>
<i>&gt;&gt;   events. After full adjustment there is a remaining significant (P &lt;</i><br>
<i>&gt;0.05)</i><br>
<i>&gt;&gt;   hazard ratio for coronary death and death from any cause and for a</i><br>
<i>&gt;coronary</i><br>

<p>
<a href="2263.html#2325qlink2">&gt;&gt;   heart disease event for those free of coronary heart disease at</a><br>
<i>&gt;baseline,</i><br>
<i>&gt;&gt;   amongst men, comparing the highest to the lowest fifth. CONCLUSION:</i><br>
<i>&gt;&gt;   Fibrinogen is a strong predictor of coronary heart disease,</i><br>
<i>&gt;&gt;   fatal or non-fatal, new or recurrent, and of death from an unspecified</i><br>
<i>&gt;cause,</i><br>
<i>&gt;&gt;   for both men and women. Its effect is only partially attributable to</i><br>
<i>&gt;other</i><br>
<i>&gt;&gt;   coronary risk factors, the most important of which is smoking.</i><br>
<i>&gt;&gt;</i><br>
<i>&gt;&gt;</i><br>
<i>&gt;&gt;</i><br>
<i>&gt; </i><br>
<!-- body="end" -->
<p>
<ul>
<!-- next="start" -->
<li><a href="2326.html">[ Next ]</a><a href="2324.html">[ Previous ]</a>
<b>In reply to:</b> <a href="2263.html">Elizabeth Childs</a>
<!-- nextthread="start" -->
<b>Next in thread:</b> <a href="2329.html">Patrick Wilken</a>
</ul>
</body></html>
